Families endorse virtual reality tumor models for pediatric oncology surgery consent

In a two-center pediatric oncology study, 88.5% of families said virtual reality (VR) tumor models should be used for all pre-surgical consent discussions; satisfaction was high, though knowledge scores increased only minimally.

• Design: Families at two pediatric oncology institutions completed disease-specific surveys after standard teaching and again after viewing their child's tumor in virtual reality.
• Secondary finding: Likert-scale and free-text feedback was positive, and parents did not report distress when viewing the tumor in VR.
• Caveat: Knowledge-question gains were minimal; the authors cite high baseline understanding or content disparities as possible explanations.

Automated summary

RadPigeon summaries are original and for information only. They are not clinical advice.